Anteris Technologies Global (AVR) Depreciation & Amortization (CF) (2024 - 2026)
Anteris Technologies Global (AVR) posted quarterly Depreciation & Amortization (CF) of $429000.0 for Q1 2026, up 6.45% year-over-year from $403000.0 in Q1 2025, and up 1.42% quarter-over-quarter from $423000.0 in Q4 2025.
Anteris Technologies Global (AVR) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Depreciation & Amortization (CF) for 3 consecutive years, with $429000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 6.45% year-over-year to $429000.0; the TTM figure through Mar 2026 stood at $1.7 million (up 7.8% YoY), while the FY2025 annual figure was $1.7 million, up 10.22% from the prior year.
- Depreciation & Amortization (CF) improved to $429000.0 in Q1 2026 per AVR's latest filing, from $423000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $429000.0 in Q1 2026 and bottomed at $345000.0 in Q1 2024.
- Historically, Depreciation & Amortization (CF) has averaged $399666.7 across 3 years, with a median of $404000.0 in 2024.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 16.81% in 2025 and fell as far as 4.7% in 2025.
- Anteris Technologies Global's Depreciation & Amortization (CF) stood at $404000.0 in 2024, then climbed by 4.7% to $423000.0 in 2025, then increased by 1.42% to $429000.0 in 2026.
- Business Quant data shows AVR's Depreciation & Amortization (CF) at $429000.0 in Q1 2026, $423000.0 in Q4 2025, and $417000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Anteris Technologies Global | 875.09 Mn | 875.09 Mn | 776,000.00 | 469,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 469,000.00 |
| Jun 30, 2026 | 469,000.00 |
| Mar 31, 2026 | 429,000.00 |
| Mar 31, 2026 | 429,000.00 |
| Dec 31, 2025 | 423,000.00 |
| Dec 31, 2025 | 423,000.00 |
| Sep 30, 2025 | 417,000.00 |
| Sep 30, 2025 | 417,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 403,000.00 |
| Mar 31, 2025 | 403,000.00 |
| Dec 31, 2024 | 404,000.00 |
| Dec 31, 2024 | 404,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 345,000.00 |
| Mar 31, 2024 | 345,000.00 |